Legal News, In Brief: FDA Opposes Otsuka Suit; Apotex Can Challenge Benicar Patent

FDA asks court to dismiss Otsuka’s Abilify suit; Apotex can seek infringement ruling on disclaimed Benicar patent; Apotex damages for omeprazole launch must be recalculated; hedge fund manager Kyle Bass files IPR petitions against Jazz and Shire.